EPS Global Medical Development Inc., a scientific and medical consultancy based in Montreal, Canada, is dedicated to create a global life science intelligent exchange channel by addressing professional needs for information and technology sharing and eliminating culture divergence in life science simultaneously. EPS Global Medical Development offers a unique blend of scientific and medical relations, collaborations and partnerships across the cultures of the East and the West. Our brand consultancy has serviced an impressive roster of institutions and international mandates.
Our rapidly growing client base in China, Japan, USA, Europe and Canada has enabled us to forge together a team of professionals that blends both youthful talent and seasoned practitioners. We are very quickly establishing ourselves as a leader in scientific, medical, public media, marketing PR, corporate and brand reputation, sponsorship, event organization and marketing and special projects.
Our corporate base is in Montreal, Canada with new offices in Beijing and Tokyo; our staffs has also been frequently entrusted to lead the creation, development and implementation of local, national and international programs for various clients across the world.
Profile
·A global scientific and medical consultancy based in Montreal, CanadaMission
·Create platforms for global networking and communicating among medical professionals and scientistsOur Strength
·Long term cooperation partnership with China medical community including governmental health organizations, professional societies, medical institutions including 30,000 hospitals and 3000,000 medical professionals
EPS CEO
EPS’s President and CEO, Dr. Yao Lu, brings a unique blend of medical practice, finance and business experience to medical consulting leadership.
EPS’s President and CEO, Dr. Yao Lu, was originally a cardiothoracic surgeon. He has fluent language skills in Chinese, English, Japanese, German, and Italian. He graduated as Ph.D. in Medicine from Freiburg University Medical School, West Germany. Afterwards, he was engaged in heart bypass surgery in the biggest heart disease hospital of South Italy. Further on, Dr. Lu pursued postdoctoral study and research at Tokyo University of Japan and Tokyo University Medical Research Institution funded by the postdoctoral scholarship from Japanese science and technology bureau and Japanese Ministry of Health. Later on, Dr. Lu launched his career as a medical researcher at the world-famous McGill University Medical School.